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Objectives: Staphylococcus haemolyticus is an emerging cause of nosocomial infections, primarily affecting
immunocompromised patients. A comparative genomic analysis was performed on clinical S. haemolyticus iso-
lates to investigate their genetic relationship and explore the coding sequences with respect to antimicrobial
resistance determinants and putative hospital adaptation.
Methods: Whole-genome sequencing was performed on 134 isolates of S. haemolyticus from geographically
diverse origins (Belgium, 2; Germany, 10; Japan, 13; Norway, 54; Spain, 2; Switzerland, 43; UK, 9; USA, 1). Each
genome was individually assembled. Protein coding sequences (CDSs) were predicted and homologous genes
were categorized into three types: Type I, core genes, homologues present in all strains; Type II, unique core
genes, homologues shared by only a subgroup of strains; and Type III, unique genes, strain-specific CDSs. The
phylogenetic relationship between the isolates was built from variable sites in the form of single nucleotide
polymorphisms (SNPs) in the core genome and used to construct a maximum likelihood phylogeny.
Results: SNPs in the genome core regions divided the isolates into one major group of 126 isolates and one minor
group of isolates with highly diverse genomes. The major group was further subdivided into seven clades (A–G),
of which four (A–D) encompassed isolates only from Europe. Antimicrobial multiresistance was observed in
77.7% of the collection. High levels of homologous recombination were detected in genes involved in adherence,
staphylococcal host adaptation and bacterial cell communication.
Conclusions: The presence of several successful and highly resistant clones underlines the adaptive potential of
this opportunistic pathogen.
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Introduction
Staphylococcus haemolyticus is an emerging cause of nosocomial
infections, in particular affecting very preterm infants and
immunosuppressed patients.1,2 Among the coagulase-negative
staphylococci (CoNS), S. haemolyticus is now the second most fre-
quently isolated species from human blood cultures, after
Staphylococcus epidermidis. S. haemolyticus is often resistant to
commonly used antimicrobial agents and is ranked as the most
antibiotic-resistant CoNS species.3 The development and spread
of antimicrobial resistance present a global threat to modern
medicine by limiting the available treatment options. Mobile gen-
etic elements (MGEs) including plasmids, prophages, transposons
and pathogenicity islands, conferring resistance to commonly
encountered antimicrobial agents, enable rapid adaption to chan-
ging environments.4 The sequence similarity of MGEs and resist-
ance genes in different Staphylococcus species suggests that
these genetic elements are readily transferred between staphylo-
cocci.5 It has been hypothesized that in Staphylococcus aureus
both the methicillin resistance gene mecA, carried on the
staphylococcal cassette chromosome (SCCmec), and the arginine
catabolic mobile element (ACME) originate from CoNS.6 This
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suggests that CoNS play an important role in the dissemination of
resistance genes,7 contributing to the emergence of epidemic
clones of the more virulent nosocomial pathogen S. aureus.
Population studies of S. aureus have revealed the establish-
ment of several successful clones.8 Whole-genome sequencing
(WGS) has offered high-resolution insight into their emergence,
expansion and transmission.9 Persistent multiresistant hospital-
adapted clones have also been detected in S. epidermidis.10 The
presence of endemic S. haemolyticus hospital clones and the
nosocomial spread of resistant clones have been reported.1
However, little is known about the population structure and the
possible emergence of hospital-adapted clones and factors con-
tributing to the persistence of S. haemolyticus in the hospital
environment. Previous molecular epidemiological analyses per-
formed by multilocus sequence typing (MLST) and multilocus vari-
able number of tandem repeats (MLVA) analysis did not confer
satisfactory discriminatory capacity for a detailed molecular epi-
demiological analysis.11 Furthermore, comparative genome stud-
ies of S. haemolyticus have to date been limited by the presence of
only one sequenced S. haemolyticus isolate (JCSC 1435).12
We performed WGS of 134 diverse geographical and temporal
clinical S. haemolyticus isolates. In order to understand the
molecular basis of the emergence of S. haemolyticus as a nosoco-
mial pathogen, we performed comparative genomic analysis of
the 134 isolates to investigate their genetic relationship and
explore their evolutionary history regarding the development of
antimicrobial resistance and adaptation. The presence of host
restriction and modification (RM) systems, which are known to
limit the interspecies and intraspecies uptake of foreign DNA,13
was investigated in order to understand the diversity of the
MGEs causing the previously high levels of antimicrobial resistance
observed in S. haemolyticus.
Materials and methods
Bacterial isolates
A total of 134 isolates of S. haemolyticus from geographically diverse origins
(Belgium, 2; Germany, 10; Japan, 13; Norway, 54; Spain, 2; Switzerland, 43;
UK, 9; and USA, 1) were sequenced (Table S1, available as Supplementary
data at JAC Online). The majority, apart from five community isolates,
were blood culture isolates from catheters or wounds, isolated within the
period from 1988–2010. The Swiss isolates were collected between 2001
and 2008, the Norwegian isolates were collected between 1988 and
2005, the UK isolates were collected in 2005 and the German and
Spanish isolates were collected in 2008, the most recently collected isolates
were from Belgium, collected in 2010. Four isolates were of animal origin
(bovine, equine and porcine). The collection represented clinical isolates
from eight countries, isolated over a 22 year period. Two large groups of iso-
lates originating from one Swiss (n¼43) and two Norwegian hospitals
(n¼54) were chosen for an investigation of clonal establishment within a
geographically confined hospital setting. The inclusion of 18 blood culture
isolates from a single neonatal unit in one of the Norwegian hospitals
allowed us to investigate local adaptation. For the sequenced clinical iso-
lates, no pre-selection based on antimicrobial resistance patterns was per-
formed. Forty-one out of 45 isolates previously typed by MLST and MLVA
were included for WGS.11 Overall the experimental design allowed an insight
with differential resolution levels into the emergence of S. haemolyticus by
investigating the establishment of international clones and the develop-
ment of clones within single wards in single hospitals.
Genomic DNA was isolated according to Chachaty and Saulnier,14 with
the addition of RNase A (10 mg/mL; Qiagen).
Susceptibility to antimicrobial agents (gentamicin, erythromycin, oxa-
cillin, fusidic acid, tetracycline, ciprofloxacin, rifampicin and vancomycin)
was performed for all isolates by Etest according to the manufacturer’s
description (AB BIODISK, Sweden). Additional susceptibility testing for tri-
methoprim, mupirocin, amikacin, linezolid, fosfomycin and daptomycin
was performed on a number on isolates. Phenotypic resistance was inter-
preted by antimicrobial breakpoints according to the EUCAST guidelines.15
Multidrug resistance was reported as resistance to more than three unique
classes of antimicrobial agents.
Genome sequencing and annotation
WGS was performed on index-tagged libraries (76 bp reads with an aver-
age insert size of 400 bp) for each S. haemolyticus strain using an Illumina
Genome Analyzer GAII as described in Bentley et al.16 Data have been
deposited in the European Nucleotide Archive under the study number
ERP000943. Each genome was assembled individually using Velvet17
and contigs.500 bp were ordered relative to the complete reference gen-
ome sequence of S. haemolyticus JCSC 1435 (AP006716) using ABACAS.18
Contigs were separated by the spacer sequence 5′-CTAGCTAGCTAG-3′
introducing stop codons in all six reading frames. Protein coding sequences
(CDSs) were predicted using Glimmer 3.19 Functional annotations were
transferred from the fully sequenced S. haemolyticus JCSC 1435. The
unique regions were annotated using an in-house genome annotation
pipeline (GePan), combining best functional hits from BLASTp,20 Pfam21
and Priam.22
Clustering of homologues
Clustering of homologous genes was performed using OrthoMCL23 on the
CDSs from all 134 S. haemolyticus isolates. In addition, the CDSs of the fully
sequenced S. haemolyticus JCSC 1435 were included in the analysis. Due to
the genome homogeny, a relatively conservative parameter configuration
for clustering was chosen. The BLAST20 percent identity cut-off was set to
70% and the OrthoMCL inflation parameter was set to 7. Unique identifiers
were assigned to each isolate and all CDSs predicted within each isolate in
the dataset. From this, each cluster of homologues was then represented
by the combination of isolates and the genes that were included in it. The
CDSs in the clusters were divided into three types: Type I, core genes,
homologues present in all strains; Type II, unique core genes, homologues
shared by only a subgroup of strains; and Type III, accessory genes, strain-
specific CDSs.
Phylogenetic analysis
Sequence reads from each strain were mapped onto the concatenated ref-
erence genome of S. haemolyticus strain JCSC 1435 (consisting of the
chromosome and three plasmids, pSHaeA, pSHaeB and pSHaeC; accession
numbers: AP006716, AP006717, AP0067178 and AP0067179) using
SSAHA v2.2.1.24 Single nucleotide polymorphisms (SNPs) were identified
as described in Croucher et al.25 SNPs in regions predicted to have arisen
by homologous recombination were identified using Gubbins25 as previ-
ously described and were excluded from the phylogenetic reconstruction.
The phylogenetic relationship between the isolates was built using RAxML
v0.7.4 from variable sites in the form of SNPs in the core genome and used
to construct a maximum likelihood phylogeny. SNPs in non-core regions of
the genome were omitted from this analysis since the non-core regions
are more susceptible to the horizontal acquisition of foreign DNA and
could confound the interpretation of the tree.
Host restriction systems
S. haemolyticus homologues of all RM enzymes in the REBASE26 were iden-
tified using BLASTp20 with an E-value cut-off,1e-5. The alignments of all
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potential matches were manually inspected to ensure that the sequences
were of similar length. Due to the fragmented nature of the assembled
genomes, the exact number of complete host restriction systems was
not determined.
Results and discussion
Genome composition
The de novo assembly generated an average of 275 contigs per
isolate. A total of 334578 CDSs were identified in 135 isolates,
including the reference strain JCSC 1435.12 OrthoMCL was used
to cluster homologues based on sequence similarity and allowed
us to group the genes into core genes that were shared among all
isolates, accessory genes shared between some but not all iso-
lates, and isolate-specific genes. All together we identified 5088
clusters, of which 1868 clusters contained core genes, 3187
were accessory gene clusters and 33 were isolate-specific clus-
ters. For each isolate, around 25.1% of the total CDSs were acces-
sory genes. These genes had either been acquired by horizontal
gene transfer (HGT) in some isolates or excised from the genetic
repertoire of others. Functional annotation of the accessory genes
and mapping against staphylococcal MGEs showed that around
half of the accessory genes were associated with MGEs. MGEs
were identified and annotated by comparing all the unique and
accessory genes against a database consisting of staphylococcal
plasmids and prophages from the European Bioinformatics
Institute27 and S. aureus pathogenicity island, transposons and
SCCmec sequences as described by Holden et al.28 The remaining
accessory genes had functions involved in metabolism, cellular
processes and signalling. Some of these genes may also reside
on novel MGEs not present in the reference set.
Phylogenetic reconstruction based on core genes
In order to discern the establishment of clones, a phylogenetic
reconstruction based on SNPs in the core regions of the genomes
was performed. This separated the 134 isolates, excluding the
JCSC 1435 strain, into one major group of 126 isolates and one
minor group comprising eight isolates. The average diversity com-
pared with the reference strain JCSC 1435 was 10495 SNPs per
genome in the major group and 64428 SNPs per genome in the
minor group. To refine the phylogeny, the eight genetically diver-
gent isolates were omitted from further analyses.
The major group of 126 isolates was subdivided into seven
clades (A–G). Clades A–D encompassed isolates from Europe
only (Figure 1), reflecting the fact that the majority of isolates
(93/126; 73.8%) originated from two hospitals in Norway and
one in Switzerland. Clade D was only found in neonatal blood cul-
ture isolates from a single Norwegian neonatal ward and isolated
during the period 1991 to 2003, 9 of the 13 isolates were isolated
between 1991 and 1999. Isolates originating from Japan were
found in Clades E–G. The increased resolution of WGS relative to
MLST allowed the separation of isolates belonging to sequence
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Figure 1. Phylogeography, recombination map and antibiotic resistance distribution of S. haemolyticus. Left panel: a maximum likelihood tree
constructed from substitutions in the core genome of S. haemolyticus. The branch length of the outgroup has been shortened by a factor of 100 for
better resolution of the tree. Branches are coloured according to geographical location. Middle panel: the chromosomal location of recombinations
detected in the collection of isolates relative to JCSC 1435. Red blocks are recombinations predicted to have occurred on an internal branch and are
shared by multiple isolates through common descent. Blue blocks are recombinations predicted to have occurred on terminal branches and are
present in only one strain. The annotations of highly variable areas are shown below. In the collection of isolates sequenced, variation predicted to
be due to recombination was identified in regions mapping to 78.1% of the JCSC1435 chromosome. Right panel: distribution of antibiotic resistance.
Coloured slots represent identified genotypes corresponding with resistance to the antibiotic class indicated below. This figure appears in colour in the
online version of JAC and in black and white in the print version of JAC.
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type (ST) 1, into the two distinct Clades A and B (ST1-A and ST1-B).
On the other hand, the congruence between WGS and PFGE was
low. This possibly reflects the variation conferred by the accessory
genes observed by PFGE, as opposed to the variation in the core
genome used to construct the phylogenetic relationship by
WGS.11 Clade C was composed of Norwegian and Swiss isolates
belonging to ST4 and ST13, while the majority of isolates in
Clade D were previously defined to be of the same (PFGE)
type.29 Interestingly, the Norwegian isolates in Clades A, B and
D originated from the same Norwegian hospital in South
Norway, while isolates from the second Norwegian hospital in
North Norway were mainly found in Clades C and E. In addition
to isolates from Norway, Clade E also consisted of closely related
S. haemolyticus isolates from Japan. The two remaining clades (F
and G) accounted for 25.6% of the major group and were com-
posed of geographically and temporally diverse isolates with a lar-
ger degree of variation as visualized by the longer branch lengths
in Figure 1. Seven of the isolates from Clades F and G were previ-
ously grouped by MLST as belonging to clonal complex (CC) 2.11
This apparent global distribution of clones not necessarily follow-
ing national borders might reflect international travel and the sub-
sequent introduction of novel successful strains.28
The extensive sampling from a single neonatal ward formed
the basis for a detailed study of a geographically constricted
group of isolates. Thirteen out of 18 isolates from this ward, iso-
lated in the period from 1991–2003 (9 of the 13 isolates were iso-
lated between 1991 and 1999), were found in Clade D. The
phylogenetic analysis suggests that this is a successful clone
that has thrived in this particular environment. The remaining
five isolates from this ward were found in Clade A and had been
isolated from 2004 to 2005, indicating that there has been a
replacement of the existing endemic clone at the neonatal ward
from 2003 onwards. A global dissemination of successful
clones, replacing established clones, due to human travel and
activity has been demonstrated for several staphylococci includ-
ing S. aureus and members of the CoNS such as S. epidermidis and
Staphylococcus hominis.28,30,31 The ability of S. haemolyticus
to disseminate and establish successful clones within European
hospitals is clearly visualized through the relatively conserved
yet geographically and temporally diverse composition of isolates
in Clade A.
Genome flexibility
The acquisition and loss of genes has shaped the genome of S. hae-
molyticus, but the genetic diversity is also the result of extensive
recombination events. Site-specific recombination generally results
in the integration or excision of DNA and can introduce MGEs into
the genome, while homologous recombination involves the recip-
rocal exchange of identical or very similar DNA.32 Frequent homolo-
gous recombination was detected in genes involved in adherence,
staphylococcal host adaptation and bacterial cell communication
(Figure 1). This includes genes such as sraP, encoding the surface
bound protein serine-rich adhesin for platelets, which is involved
in bacterial aggregation in S. haemolyticus,12 and the mannitol-
specific phosphotransferase genes (mtlD and mtlA). Evidence of
frequent recombination in sraP was found as the pattern of vari-
ation in isolates belonging to Clades A–F showed individual recom-
binatory patterns. mtlD and mtlA, important in distinguishing
S. aureus, Staphylococcus saprophyticus and S. haemolyticus from
other staphylococcal species, were detected in 90 isolates.12 In
S. aureus mannitol metabolism is important in response to anti-
microbial fatty acids secreted on the skin and in abscesses by the
innate immune system. S. aureus mtlD mutants displayed reduced
growth in the presence of long chain fatty acids and increased sus-
ceptibility to H2O2.
33 From the high prevalence in our collection
(90/126), it is likely that the mtl operon is equally important for sur-
vival and host adaption in S. haemolyticus. Both sraP and the mtl
genes are located in the oriC environs and the mtl genes have pre-
viously been reported to be easily lost in S. haemolyticus, indicating
horizontal acquisition.12 sraP is flanked by transposon ISSha1, pos-
sibly contributing to mobilization.
The distribution of SNPs in the isolates in Clades A–G relative to
the JCSC 1435 reference genome displays conserved regions, inter-
spersed with highly variable regions throughout the genome
(Figure 1). In particular, the region designated the oriC environs,
which among others harbours SCCmec, is highly variable in our iso-
lates. The high number of different recombinases (n¼6) and SCC
elements (Table 1) may act as mediators for the frequent recom-
bination events. The oriC environs has been suggested to confer a
diversifying power separating the different staphylococcal species,
enabling adaption to survival within the human host by acting as a
hotspot of recombination.12 Our analyses show that differential
recombinations within the oriC environs contribute to an increased
diversity in S. haemolyticus, both within and between different
clades. S. aureus is dominated by a few major clones in which
recombination occurs but on a smaller scale.8,34 Recombination
resulting in positive selection has been shown to function as an
evolutionary driving force in other bacterial genomes.35,36 It is pos-
sible that the overall high recombination frequency in S. haemoly-
ticus reflects an ongoing adaption to a recent change in lifestyle or
Table 1. Type and prevalence of recombinases and mec gene complexes
ccr gene complex47 mec gene complex47 No of isolates
AB1 class C 3
AB3 class C 4
AB1+ABSHP class C 4
AB1+ABSHP+C class C 1
AB2 class C 2
AB2+AB4 class A 1
AB2, AB4, ABSHP, CcrC class A 2
AB3 class C 4
AB3+ABSHP class C 1
AB3+C class C 1
AB4 class C 37
AB4+C class C 5
AB4+ABSHP class C 2
C class C 25
No recombinases class C 15
C D mecA 3
AB4 D mecA 3
AB1 D mecA 3
AB1+AB4 D mecA 1
A1B1+AB3 D mecA 1
AB4+ABSHP D mecA 1
AB4+C D mecA 3
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selective pressure associated with the rather recent emergence of
S. haemolyticus as an opportunistic pathogen in the hospital niche
primarily associated with immunocompromised patients.
Host RM systems
It has been demonstrated that the Type I and III RM systems pre-
vent HGT by the recognition and removal of exogenous unmethy-
lated DNA, whereas the Type IV RM cleaves DNA upon the
recognition of modified cysteine residues.13 In our strain collection,
Type I, Type II, Type III and Type IV RM systems were detected and
several isolates harboured more than one RM system (Table S2,
available as Supplementary data at JAC Online). Fifteen isolates
harboured a functional RM system homologous to Sau1 Type I,37
15 isolates had a Type II RM system, homologous to Sau3AI38
and 55 isolates had a Type IV system homologous to SauUSI.39
These RM systems have been described in S. aureus. As they may
provide barriers to the exchange of genetic material, the number
of RM systems is surprisingly high relative to the large presence of
MGEs. However, within distinct RM groups there could be extensive
genetic exchange. Recent studies have pointed to additional func-
tions of RM systems, such as bacterial cell death as a result of RM
systems acting as selfish DNA, maintaining their own existence in
bacterial genomes.40 Additionally, RM systems are often co-localized
on MGEs, possibly stabilizing the maintenance of these genes in the
host.40
Antimicrobial resistance determinants
S. haemolyticus has previously been reported to be multiresistant,3
and in this study multiresistance (i.e. resistance to at least three
antimicrobial classes) was observed in 105/135 (77.7%) isolates
(Table 2). The clade-wise prevalence of different antimicrobial resist-
ance genes is shown in Figure 1 and the genes conferring resistance
are listed in Table S1. Resistance to linezolid and vancomycin was
not detected. Phenotypic observations of resistance correlated
well with the cognate resistance genes. Discrepancy values ranged
from 0.7% to 3.7% for aminoglycosides, macrolides, b-lactams
(blaZ and mecA), fluoroquinolones, rifampicin, quaternary ammo-
nium compounds and trimethoprim.
The horizontal transfer of resistance genes located on plasmids
was apparent by variability not only between, but also within the
clades. Plasmids encoding resistance to fosfomycin (fosB), fusidic
acid (fusB), tetracycline [tet(L) or tet(M)], quaternary ammonium
compounds (qacA or qacG), macrolides– lincosamides [erm(C),
erm(A) or vga(A)] and trimethoprim (dfrD) were not uniformly dis-
tributed within the clades. Clades A and B were differentiated by
the carriage of erm(C) and tet(L), respectively, whereas in Clade D
no plasmids carrying erm(C), tet(L) or fosB were found. Plasmids
carrying fosBwere found in Swiss, German and Norwegian isolates
in Clade A and in Japanese and Swiss isolates in Clade E and
G. Fosfomycin has commonly been used in treatment of uncom-
plicated urinary tract infections but has now been reconsidered
for the treatment of methicillin-resistant S. aureus (MRSA) infec-
tions. In Germany and Japan treatment with intravenous fosfo-
mycin has been used successfully for four decades,41,42 and the
resistance rates in German and Japanese isolates in our collection
were 50.0% and 46%, respectively. It is worth noting that fosB is
found only in isolates from the year 2000 onwards, possibly indi-
cating a recent increase in resistance.
Plasmids encoding resistance to quaternary ammonium com-
pounds (qacA, qacC and qacG), used in disinfectants,43 were
widely distributed in all clades.
Fluoroquinolone resistance was caused by point mutations
generating substitutions Ser80Phe in topoisomerase IV (GrlA)
and Ser84Leu in gyrase A (GyrA). A total of 75/84 of the isolates
dating from 2000 onwards, mainly found in Clades A, B, C and F,
showed fluoroquinolone resistance. In contrast, isolates in Clade
D, mainly isolated from 1990 to 2000, did not harbour these
mutations. The observed fluoroquinolone resistance in isolates
dating from 2000 onwards correlates well with the introduction
and increase in usage of fluoroquinolones in European hospitals
in the 1990s.44 In S. aureus fluoroquinolone resistance is asso-
ciated with the emergence of MRSA and the successful S. aureus
pandemic EMRSA-15 clone.28 Fluoroquinolones are commonly
used to treat infections other than staphylococcal infections, so
resistance might be beneficial for survival on human skin as fluor-
oquinolones are secreted in sweat and might affect skin commen-
sals such as staphylococci.28 It is likely that the widespread use of
antimicrobial agents has promoted the development of resistant
clones of S. haemolyticus persisting in the hospital environment,
Table 2. Prevalence of antimicrobial resistance in the sequenced S. haemolyticus collection according to geographical origin
Country Number
Presence of genes and mutations conferring antimicrobial resistance (%)
GEN ERY OXA FUS TET CIP RIF TMP QAC FOF
Belgium 2 100 100 100 100 100 100 0 100 100 0
Germany 10 90 90 90 40 10 90 20 40 90 50
Japan 14 64 64 100 0 43 57 0 0 21 46
Norway 54 83 74 83 35 30 41 0 11 69 7
Spain 2 100 50 100 50 50 100 0 100 50 0
Switzerland 43 79 90 70 42 28 63 2 12 79 33
UK 9 78 78 78 44 67 67 22 56 78 22
USA 1 100 0 100 0 0 0 0 0 0 0
GEN, gentamicin; ERY, erythromycin; OXA, oxacillin; FUS, fusidic acid; TET, tetracycline; CIP, ciprofloxacin; RIF, rifampicin; TMP, trimethoprim;
QAC, quaternary ammonium compounds; FOF, fosfomycin.
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which have responded by the acquisition of MGEs or beneficial
core mutations. The uptake and loss of MGEs reflects the continu-
ous and dynamic local adaption protecting the staphylococci
from antimicrobial agents circulating in the hospital environment,
thus enabling rapid adaption to changes in selective pressure.45
SCCmec and ACME
The majority of the isolates (107/126; 84.9%) carried SCCmec
(Table 1), encoding methicillin resistance by the production of
alternative penicillin-binding protein, Pbp2a.46 In 62 of the
mecA-positive isolates, mainly isolates belonging to Clades A
and C, the regulatory gene mecR1 was absent. The composition
of the mec class was otherwise identical to SCCmec class C.47
S. haemolyticus isolates lacking the regulatory genes have previ-
ously been reported, albeit to a lesser extent.48 The absence of
mecR1 has been demonstrated not to interfere with the expres-
sion of mecA. This correlates well with phenotypic data showing
that methicillin resistance was expressed in isolates lacking
mecRI. Twenty-eight isolates had the previously described mec
gene complexes C and A.47 ccr complex AB4 (31.7%) followed
by ccrC (22.2%) were the most prevalent recombinases in our col-
lection. Seventeen of the mecA-positive isolates harboured more
than one type of recombinase, whereas 15 isolates harboured
mecA but lacked ccr recombinase. Fifteen of the mecA-negative
isolates harboured at least one set of ccr genes. A variation in
the combination of recombinases with the mecA element has pre-
viously been reported for S. haemolyticus, indicating that it plays
an important role in adaption.49
The ACME is a genetic island integrated in orfX next to SCCmec.50
The arc and/or opp3 gene clusters encode one complete deaminase
pathway and one oligopeptide permease system, respectively.50
ACME arcA was not detected in our S. haemolyticus collection. The
novel allotypes ccrA-SHP and ccrB-SHP previously described in associ-
ation with ACME arcA in S. haemolyticus were detected in 19 iso-
lates.51 A low prevalence of ACME arcA in S. haemolyticus was
previously reported by Onishi et al.,52 where ACME arcA was most
prevalent in S. epidermidis.
Clustered regularly interspaced short palindromic repeats
(CRISPRs) are known to limit the uptake of exogenous DNA.53
Only one isolate harboured what seemed to be a complete
CRISPR system. This system had high sequence identity to the
CRISPR genes found in Staphylococcus lugdunensis (GenBank
accession number CP001837). The lack of functional CRISPR
genes in most of the S. haemolyticus isolates examined could sup-
port the observed frequent uptake of MGEs.54
Conclusions
We report for the first time the population structure of a large col-
lection of clinical European S. haemolyticus isolates. Several multi-
ply antibiotic-resistant European clones were detected, displaying
the effects of antibiotic treatment on forming successful lineages.
The presence of multinational clones with very recent separation
in conserved clades may be an effect of human travel activity
rather than a parallel evolution in different countries.
The majority of the collection was multiresistant, which corro-
borates previous observations of multiresistance in this species.
The consequences of DNA acquisition and excision have been
important in evolutionary terms since as many as one-fifth of
the genes are part of the accessory genome and not shared by
all the isolates. Recombination has also contributed significantly
in shaping the genome as the SNP distribution pattern varies in dif-
ferent genomic regions, resulting in regional hotspots of recom-
bination such as the oriC environs. The variation in the presence
and level of recombination in surface-associated proteins and
genes involved in pathogenicity, as well as bacterial communica-
tion in hospital-adapted isolates, indicate that these genes play
an important role in the interaction between S. haemolyticus
and the host. Both the frequent exchange of DNA and a high
degree of recombination support the previous observation that
S. haemolyticus has a highly flexible genome.12
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